RC

Rob Cannon

Interim CCO, Vice-President, North America

KORU Medical Systems

Therapeutic Areas

KORU Medical Systems Pipeline

DrugIndicationPhase
FreedomEDGE® + RYSTIGGO®Generalized Myasthenia GravisCleared
Freedom™ System + SCIgPrimary Immunodeficiencies, CIDPCommercial